Kolexia
Pracht Marc Oncologie médicale
Pracht Marc
Oncologie médicale
Centre Eugène Marquis
Rennes, France
333 Activités
746 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome hépatocellulaire Carcinomes Tumeurs du foie Mélanome Métastase tumorale Cholangiocarcinome Tumeurs cutanées Tumeurs colorectales Tumeurs neuroendocrines

Collaborateurs

Voir plus
Edeline Julien
Edeline Julien
Centre Eugène Marquis, Rennes, France
Rolland Yan
Rolland Yan
Centre Eugène Marquis, Rennes, France
Le Sourd Samuel
Le Sourd Samuel
Centre Eugène Marquis, Rennes, France
Garin Etienne
Garin Etienne
Centre Eugène Marquis, Rennes, France

Industries

Voir plus
Ipsen
12 collaboration(s)
Dernière en 2023
Advanced Accelerator Applications
8 collaboration(s)
Dernière en 2022
MSD
6 collaboration(s)
Dernière en 2023
B3TSI
4 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
RELATIVITY-127: A Phase 3, Randomized, Open-label, Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination Versus Intravenous Nivolumab + Relatlimab Fixed-dose Combination in Participants With Previously Untreated Metastatic or Unresectable Melanoma
Essai Clinique (BMS)   29 février 2024
BETTER2: Randomized Phase 2 Trial Of Two Chemotherapy Regimens Plus Or Minus Bevacizumab In Patients With Well Differentiated Pancreatic Neuroendocrine Tumors
Essai Clinique (Gustave-Roussy)   07 février 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024
A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma: An Open-Label Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Subjects With Hepatocellular Carcinoma
Essai Clinique (Eisai)   20 novembre 2023
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   02 novembre 2023
132MO Molecular profiling of 991 prospectively recruited rare cancers patients in EUROPE: First results of ARCAGEN – an EORTC-SPECTA and EURACAN study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1130P Tebentafusp (tebe) in an ongoing cohort of 72 French patients (pts) with metastatic uveal melanoma (mUM)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten): Randomized, Multicentre, Phase II Study Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After at Least 10 Years of Treatment in Patients With Locally Advanced/Metastatic Gastrointestinal Stromal Tumors (GISTs)
Essai Clinique (Centre Léon-Bérard)   31 août 2023
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life study.
Journal of the European Academy of Dermatology and Venereology : JEADV   18 août 2023
OSCAR: Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023